Hunterdon Regional Cancer Center — Flemington, New Jersey

Hunterdon Regional Cancer Center is a clinical research site located in Flemington, New Jersey, United States 08822.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Hunterdon Regional Cancer Center has participated in 20 clinical trials.

Therapeutic areas: SARS-CoV-2 Infection, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Lymphoma.

Sponsors: MediMergent, LLC, Celldex Therapeutics, Eastern Cooperative Oncology Group.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hunterdon Regional Cancer Center?

Hunterdon Regional Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hunterdon Regional Cancer Center conducted?

Hunterdon Regional Cancer Center has 20 clinical trials on record. Their work covers SARS-CoV-2 Infection, Metastatic gpNMB Over-expressing Triple Negative Breast Cancer, Lymphoma.

Is Hunterdon Regional Cancer Center accredited by Crixeo Health?

Yes — Hunterdon Regional Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Hunterdon Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.